Wednesday, 17 August 2022

 

 

LATEST NEWS First Of Its Kind Collaboration (Jashn E Kashmir) Between Punjabi And Kashmiri Artists Pulls Youth In The Valley Secrets: The PropheC Drops Captivating Teaser Of Upcoming Track. Video Inside Andhra Pradesh to get Rs 1.54 lakh cr investment in 2 years Drashti Dhami reveals what made her say yes to 'Duranga' Akshay Kumar grooves to 'Main Khiladi Tu Anari' after 28 years for 'Selfiee' Father's friends rape teenage daughter, one arrested in Kerala Kriti Sanon wants Vijay Devarakonda, Kartik Aaryan, Ryan Gosling in her swayamwar Asaduddin Owaisi slams Centre over targeted killings of Kashmiri Pandits Ireland all-rounder Kevin O'Brien retires from international cricket Basavaraj Bommai supports BJP minister after his 'no functioning govt in Karnataka remark Indices end higher for third straight session, Sensex closes at 58,842 Pulkit Bangia calls 'Kumkum Bhagya' life changing break 'Squid Game' wins two prizes at US critics' awards Prateik Babbar, Simi Chahal's 'Tere Bajjon' is an emotional rollercoaster Nitish Kumar calls 1st cabinet meeting to distribute portfolios to ministers On TV, you just get lost : Aly Goni Ranjit Bawa Is Soon To Hit Music Charts With His Debut EP. Shares Details On IG Stories Adal Badal: After Shershaah, Kiara Advani & Sidharth Malhotra To Share Screen In Upcoming Rom-Com Film Sidharth Malhotra finally reveals his 'future plans' with Kiara on 'Koffee With Karan' Defence Minister Rajnath Singh hands over multiple indigenous weapons to Army Kamal Haasan-starrer 'Vikram' completes 75 days in theatres

 

Mylan launches remdesivir supply in India under 'DESREM' name

Web Admin

Web Admin

5 Dariya News

Bangalore , 20 Jul 2020

Global pharmaceutical company Mylan on Monday announced the commercial launch of the generic version of Gilead Sciences's antiviral drug remdesivir under the brand name  'DESREM' in India to address urgent needs amid Covid-19.Available at a price of Rs 4,800 per 100mg vial, the drug costs more than 80 per cent less than the price at which the  branded version of this product will be available to governments in the developed world, Mylan said.The drug can be used for the treatment of suspected or laboratory confirmed  incidences of Covid-19 in adults and children hospitalised with severe presentations of the disease.Releasing the first batch of its generic remdesivir (DESREM), Mylan said it will  continue to increase its supply across the country in the wake of the rising demand for the drug.The company also launched a 24/7 helpline where patients and healthcare  practitioners can access information about Mylan's remdesivir and its availability."With the launch of DESREMTM and our national 24/7 Covid-19 helpline, we aim to enhance  access to this critical medicine, used for treating adults and children with severe presentations of Covid-19," Rakesh Bamzai, President, India and Emerging Markets, Mylan, said  in a statement.Mylan said it will manufacture DESREM in its facility in Bengaluru, which will work to service the demand in India and other export markets where Mylan has  received a license from Gilead for the commercialisation of remdesivir.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Corona Virus Updates , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , Global pharmaceutical company , Mylan , DESREM

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD